Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

In its third quarter results of 2024, pharmaceutical giant GSK confirmed it would pay a quarterly dividend of 15 pence. However, Morningstar analyst Christopher Johnson says he believes that GSK’s ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Chronic HBV kills around 900,000 people every year, said GSK. The company's head of development, Chris Corsico ... Discover how AI is transforming the pharma commercial strategy.

"The rationale for an ongoing investment in the consumer business will need to be explained by the executives," commented Chris ... for the pharma business that can be reinvested into GSK's ...

Chris Beauchamp, chief market analyst at IG ... down 928p to 10,114p, Hikma Pharmaceuticals, down 36p to 1,820p, GSK, down 22 ...

Eagle Pharmaceuticals (EGRX) announced the appointment of Christopher Krawtschuk as CFO of the Company, effective November 11, 2024. In connection with Mr. Krawtschuk’s appointment, Steven Ratoff ...

GSK has spent slightly more on lobbying this year compared with 2023. The company spent $3.87 million in the first three ...

WOODCLIFF LAKE, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced the appointment of Christopher Krawtschuk as Chief ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...

WELCOME BACK: Drugmakers’ top lobbying group is welcoming lawmakers back to town this week with a seven-figure ad blitz, ramping up pressure on Congress to enact a crackdown on pharmaceutical ...

WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the ...